4th vaccination for immunocompromised and nursing hospital residents… Side effects remain
On the 14th, the 4th COVID-19 vaccine and Novavax vaccine were started for immunocompromised persons and residents of nursing hospitals and facilities. In a regular briefing on the 14th, the government announced through a regular briefing that as the number of confirmed cases of the elderly recently increased again, additional vaccinations would be given to […]
‘Traditional’ Novavax Corona Vaccine Approved… “Priority for the unvaccinated”
The coronavirus vaccine made by Novavax in the US will be used in Korea from next month. Some say that it is safer because it is made in the same way as the vaccines we have been given so far, such as influenza and hepatitis B injections. The government plans to use this first for […]
Prime Minister Kim “Decision to approve Novavax vaccine today…Introduced an edible treatment tomorrow”
[사진 제공: 연합뉴스] The final decision will be made today on whether or not to approve Novavax’s COVID-19 vaccine manufactured using the synthetic antigen method. Prime Minister Kim Bu-gyeom said at a meeting of the Daily Recovery Support Committee today, “Once the approval is decided, we can choose another vaccine, and it will help to […]
EU approves emergency use of Novavax vaccine… Pre-contract for 200 million servings
A recombinant protein COVID-19 vaccine developed by Novavax. Source = Novavax [이코노믹리뷰=황진중 기자] The European Union (EU) has approved the emergency use of the US biotech Novavax’s COVID-19 vaccine. According to the Financial Times (FT) on the 20th (local time), the European Commission made a final decision on the emergency use of Novavax vaccine for […]
EU approves Novavax vaccine “90% preventative”… Station ‘5th’
A coronavirus vaccine developed by US pharmaceutical company Novavax has been conditionally approved for sale in Europe. In a clinical trial on adults 18 years of age and older, it was estimated that the effectiveness of preventing the corona virus reached 90%. Correspondent Kim Jung-woo. The European Commission has approved the conditional sale of a […]
EU approves conditional sale of Novavax vaccine… “Preventive effect 90%”
A coronavirus vaccine developed by US pharmaceutical company Novavax has been approved for conditional sale in Europe. In a clinical trial on adults 18 years of age and older, it was estimated that the prevention effect of Corona reached 90%. Correspondent Kim Jung-woo. The European Commission has approved the conditional sale of a COVID-19 vaccine […]
Omicron confirmed in 43 countries around the world… More than 10,000 confirmed cases in 12 US states and South Africa
Expansion from external influx to local infection… The US is also concerned about dominant speciesNovavax “Possible to produce Omicron vaccine next month”Some experts say, “Unlike Delta, there are no major symptoms such as shortness of breath.”Analysis of “mixed with cold virus” ▲ Passengers are waiting for a taxi at a taxi stand in Soweto, South […]
[뉴욕증시 포커스] Omicron falls on fears of premature Fed tightening… Nasdaq 1.55%↓
New York stocks fell sharply on concerns about the spread of the new mutant virus and the remarks of Chairman Powell. source = news [이코노믹리뷰=노성인 기자] New York stocks fell on fears of the new coronavirus mutant Omicron and the Fed’s hawkish remarks. On the 30th (local time) on the New York Stock Exchange (NYSE), […]
Ministry of Food and Drug Safety, Novavax Corona 19 Vaccine License Review Begins
The Ministry of Food and Drug Safety announced that SK Bioscience applied for a manufacturing and sales license for the U.S. Novavax Corona 19 vaccine today (15th) and started the review. This vaccine is a recombinant protein vaccine that produces antibodies by injecting the coronavirus antigen protein into the body. It is characterized by a […]
Novavax approves emergency use of coronavirus vaccine in Indonesia… “SK vasa expects domestic application”
An SK Bioscience employee is inspecting a vaccine production facility. Source = SK Bioscience [이코노믹리뷰=황진중 기자] Novavax announced on the 1st (local time) that it has received the first Emergency Use Authorization (EUA) from the Indonesian regulatory authority for the COVID-19 vaccine ‘NVX-CoV2373’. In Korea, it is expected that SK Bioscience (302440), which is a […]
